As one of the world’s most active centers for the care of myeloproliferative disorders, MD Anderson has a level of experience and expertise that can make a profound difference in your treatment. Our experts design your personal care plan specifically for you, drawing upon the most advanced options with the least impact on your body.
We are at the forefront of developing new cancer treatments for MPD, including innovative drugs to improve blood counts. As one of the nation’s leading MPD research programs, we are able to offer clinical trials of investigational agents, while most other cancer centers do not.
Myeloproliferative Disorder Treatments
Myeloproliferative neoplasms are often challenging to treat, and it may require years of therapy and follow-up care. Treatments for MPD generally are aimed at controlling disease symptoms, and your symptoms will help the doctor decide which treatment is best. Therapies may include one or more of the following.
- Medications: Aspirin, hydroxyurea, anagrelide and interferon-alpha are the main medications for essential thrombocytemia and polycythemia vera. Thalidomide, steroids and other hormones, and cladribine and busulfan also may be used.
- Blood or platelet transfusion
- Growth factors, which stimulate growth of bone marrow cells, are given as injections under the skin and may benefit patients with low blood cell counts.
- Radiation therapy
- Surgical removal of the spleen
MD Anderson patients have access to clinical trials offering
promising new treatments that cannot be found anywhere else.
Find the latest news and information about myeloproliferative
disorder in our Knowledge Center, including blog posts, articles,
videos, news releases and more.
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.